Aboukais R, Bonne N-X, Baroncini M, Zairi F, Schapira S, Vincent C, Lejeune J-P
Department of Neurosurgery, Lille University Hospital, rue E.-Lainé, 59037 Lille cedex, France.
Department of Otology and Neurotology, Lille University Hospital, rue E.-Lainé, 59037 Lille cedex, France.
Neurochirurgie. 2018 Nov;64(5):364-369. doi: 10.1016/j.neuchi.2014.11.012. Epub 2015 Jun 10.
Neurofibromatosis type 2 is characterized by the presence of bilateral vestibular schwannomas. However, other nervous system tumors may also occur. Therefore, the management of NF2 patients is complex and requires a multidisciplinary discussion in a specialized center.
All recent articles concerning tumors other than vestibular schwannoma in NF2 disease were reviewed, using PubMed databases.
Intracranial meningiomas occur in 50% of NF2 patients, and are often multiple. Surgery remains the main treatment and should be performed in cases of growing tumors. The role of antiangiogenic therapy is currently under evaluation and the role of radiosurgery still remains to be defined in NF2 disease. Spinal tumors occur in about half of NF2 patients. Surgery should be discussed when radiological tumor progression is demonstrated, even if spinal tumors are asymptomatic, in order to preserve neurological function and good quality of life. As regards lower cranial nerve schwannomas, radiosurgery appears to be a more appropriate treatment for growing tumor with a small volume in order to avoid post-operative complications, especially swallowing disorders. Facial nerve schwannomas may appear, on MRI, like vestibular schwannomas. The diagnosis should be suspected when the facial palsy is an early symptom during cerebello-pontine tumor progression. Trigeminal schwannomas are frequent in NF2 disease and fortunately they are often asymptomatic. Among major neurofibromatosis types, peripheral nerve sheath schwannomas are only present in patients with NF2 disease and schwannomatosis. Surgical resection is required when the cutaneous schwannomas is painful or when tumor progression is observed and causes symptoms.
Tumors other than vestibular schwannoma are also associated with a poor prognosis in NF2 patients. Surgery remains the main treatment in most cases. Each treatment decision in NF2 disease requires a complete evaluation of all cranial and spinal locations of the disease in order to establish surgical priorities and strategies.
2型神经纤维瘤病的特征是双侧前庭神经鞘瘤。然而,其他神经系统肿瘤也可能发生。因此,NF2患者的管理很复杂,需要在专业中心进行多学科讨论。
使用PubMed数据库对所有近期有关NF2疾病中除前庭神经鞘瘤以外的肿瘤的文章进行了综述。
50%的NF2患者会发生颅内脑膜瘤,且通常为多发。手术仍然是主要治疗方法,对于肿瘤生长的病例应进行手术。抗血管生成疗法的作用目前正在评估中,放射外科在NF2疾病中的作用仍有待确定。约一半的NF2患者会发生脊柱肿瘤。即使脊柱肿瘤无症状,当影像学显示肿瘤进展时,也应讨论手术,以保留神经功能和良好的生活质量。对于低位颅神经鞘瘤,放射外科似乎是治疗体积小且生长的肿瘤的更合适方法,以避免术后并发症,尤其是吞咽障碍。面神经鞘瘤在MRI上可能表现得像前庭神经鞘瘤。当面瘫是桥小脑角肿瘤进展过程中的早期症状时,应怀疑该诊断。三叉神经鞘瘤在NF2疾病中很常见,幸运的是它们通常无症状。在主要的神经纤维瘤病类型中,周围神经鞘瘤仅见于NF2疾病和神经鞘瘤病患者。当皮肤神经鞘瘤疼痛或观察到肿瘤进展并引起症状时,需要进行手术切除。
除前庭神经鞘瘤以外的肿瘤在NF2患者中也与不良预后相关。在大多数情况下,手术仍然是主要治疗方法。NF2疾病中的每一个治疗决策都需要对疾病在所有颅部和脊柱部位进行全面评估,以确定手术优先级和策略。